Cyclohexyl(propan-2-yl)azanium;tris(2,3,4,5,6-pentafluorophenyl)boranuide
C27H21BF15N — CID 139120957
Data last refreshed: (MolForge compound catalog, from PubChem)
About Cyclohexyl(propan-2-yl)azanium;tris(2,3,4,5,6-pentafluorophenyl)boranuide
Cyclohexyl(propan-2-yl)azanium;tris(2,3,4,5,6-pentafluorophenyl)boranuide (PubChem CID 139120957) has the molecular formula C27H21BF15N and a molecular weight of 655.25 g/mol. Its IUPAC name is cyclohexyl(propan-2-yl)azanium;tris(2,3,4,5,6-pentafluorophenyl)boranuide.
Molecular Properties
| Compound Name | Cyclohexyl(propan-2-yl)azanium;tris(2,3,4,5,6-pentafluorophenyl)boranuide |
|---|---|
| PubChem CID | 139120957 |
| Molecular Formula | C27H21BF15N |
| Molecular Weight | 655.25 g/mol |
| Exact Mass | 655.15 |
| IUPAC Name | cyclohexyl(propan-2-yl)azanium;tris(2,3,4,5,6-pentafluorophenyl)boranuide |
| SMILES | CC(C)[NH2+]C1CCCCC1.Fc1c(F)c(F)c([BH-](c2c(F)c(F)c(F)c(F)c2F)c2c(F)c(F)c(F)c(F)c2F)c(F)c1F |
| InChI | InChI=1S/C18HBF15.C9H19N/c20-4-1(5(21)11(27)16(32)10(4)26)19(2-6(22)12(28)17(33)13(29)7(2)23)3-8(24)14(30)18(34)15(31)9(3)25;1-8(2)10-9-6-4-3-5-7-9/h19H;8-10H,3-7H2,1-2H3/q-1;/p+1 |
| InChIKey | AZIZTGMBSJNETR-UHFFFAOYSA-O |
| XLogP | 5.31 |
| TPSA | 16.61 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | |
| Rotatable Bonds | 5 |
| Heavy Atoms | 44 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 655.25 |
| LogP ≤ 5 | 5.31 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 0 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'halogenated_ring_1', 'substructure': 'N/A'}, {'alert_name': 'halogenated_ring_2', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 139120957 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.